| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 09/25/2007 | CA2415551C Aniline derivatives |
| 09/20/2007 | WO2007106705A1 Soluble epoxide hydrolase inhibitors and methods of using same |
| 09/20/2007 | WO2007106525A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 09/20/2007 | WO2007106330A1 Metal carboxylate salt nucleating or clarifying agent compounds and related polymer compositions and methods |
| 09/20/2007 | WO2007105989A2 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library |
| 09/20/2007 | WO2007105650A1 4-hydroxyisoleucine derivative and process for producing the derivative |
| 09/20/2007 | WO2007104696A1 Antimalarial agents having polyaromatic structure |
| 09/20/2007 | WO2007104144A1 Compounds, ionic liquids, molten salts and uses thereof |
| 09/20/2007 | US20070219374 Method of Producing Aminophenol Compounds |
| 09/20/2007 | US20070219372 Novel Amination Process |
| 09/20/2007 | CA2646154A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 09/20/2007 | CA2643859A1 Soluble epoxide hydrolase inhibitors and methods of using same |
| 09/19/2007 | EP1833810A1 Crystalline modifications of n-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino-(l)-phenylalanine-4-ethoxycarbonylpiperazide and/or salts thereof |
| 09/19/2007 | EP1622867B1 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 09/19/2007 | EP1594836B1 Hydroxy-tetrahydro-naphthalenylurea derivatives |
| 09/19/2007 | EP1585734A4 Anti-inflammatory medicaments |
| 09/19/2007 | CN101039928A Method for cleaning 3-hydroxyamidinophenylalanine derivatives by the precipitation and recrystallisation of a salt and an aromatic sulphonic acid |
| 09/19/2007 | CN101039927A Serotonin 5-HT3 receptor agonist |
| 09/19/2007 | CN101037423A High spermidine conjugates, preparation and application thereof |
| 09/19/2007 | CN100338047C Process for the preparation of pyrazolopyrimidin ones |
| 09/19/2007 | CN100338046C Antimalarial and anti-babesiosis agent and pharmaceutical compositions contg. same |
| 09/19/2007 | CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 09/19/2007 | CN100338034C Insect repellents |
| 09/18/2007 | US7271292 Process for distillatively removing piperazine from an ethylenediamine-piperazine mixture |
| 09/18/2007 | US7271289 4'-(azetidin-1-ylcarbonyl)-N-cyclopropyl-5-fluoro-6-methyl-1,1'-biphenyl-3-carboxamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis |
| 09/18/2007 | US7271264 Pentacyclic oxepines and derivatives thereof, compositions and methods |
| 09/18/2007 | US7271195 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease |
| 09/18/2007 | US7271168 Piperazine derivatives having SST1 antagonistic activity |
| 09/18/2007 | CA2411957C Novel process for the preparation of pyrazolopyrimidinones |
| 09/18/2007 | CA2287991C New benzylamine derivatives and phenylethylamine derivatives, process for preparing them and their use as medicaments |
| 09/18/2007 | CA2263362C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 09/18/2007 | CA2211982C Substituted indanylidineacetylguanidines, process for their preparation,their use as medicaments or diagnostic and medicaments containing them |
| 09/18/2007 | CA2095797C Arylacetamides |
| 09/13/2007 | WO2007102392A1 Mmp-13-selective inhibitor |
| 09/13/2007 | WO2007101864A2 Compounds that modulate ppar activity, their preparation and use |
| 09/13/2007 | WO2007071766A3 Phenoxy acetic acids as ppar delta activators |
| 09/13/2007 | WO2006106244A3 Method for preparing $g(b)-amino esters or $g(a)-, $g(b)-diamino esters derived from serine |
| 09/13/2007 | US20070213364 Alkoxyphenylpropanoic Acid Derivatives |
| 09/13/2007 | US20070213348 Chemical Compounds |
| 09/13/2007 | US20070213336 peroxisome proliferator activated receptor agonists, such as (E)-3-[3'-(3-heptyl-1-methylureido)biphenyl-4-yl]acrylic acid, useful in human or veterinary medicine (in dermatology, cardiovascular diseases, immune diseases and/or metabolism of lipids); cosmetics |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213331 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 09/13/2007 | US20070213329 Sulphones which modulate the action of gammasecretase |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | CA2645719A1 Compounds that modulate ppar activity, their preparation and use |
| 09/12/2007 | EP1832580A1 Crystal and salt of 1-cyclopropylmethyl-4-ý2-(3,3,5,5)-tetramethylcyclohexyl)phenyl¨piperazine |
| 09/12/2007 | EP1831189A1 Tetralin and indane derivatives and uses thereof |
| 09/12/2007 | EP1831188A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 09/12/2007 | EP1831179A1 Method for the production of onium salts with tetrafluoroborate anion having a reduced halide content |
| 09/12/2007 | EP1831164A1 Heterocyclic compounds as ccr2b antagonists |
| 09/12/2007 | EP1831153A2 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases |
| 09/12/2007 | EP1831149A1 Novel ligands that modulate rar receptors and use thereof in human medicine and in cosmetics |
| 09/12/2007 | EP1372615A4 Compounds and compositions for delivering active agents |
| 09/12/2007 | EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/12/2007 | CN101035777A Modulators of hcv replication |
| 09/12/2007 | CN101035774A Modulators of CRTH-2 receptor activity for the treatment of prostaglandin D2 mediated diseases |
| 09/12/2007 | CN101035526A Ophthalmic compositions for treating ocular hypertension |
| 09/12/2007 | CN100336797C Tetra substituted chalcone derivative and preparing method and use |
| 09/11/2007 | US7268256 Method of purifying quaternary alkyl ammonium salt and quaternary alkyl ammonium salt |
| 09/11/2007 | US7268232 Androgen receptor modulators and method of treating disease using the same |
| 09/11/2007 | US7268153 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| 09/11/2007 | US7268140 (2S)-1-((4-chlorophenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES |
| 09/11/2007 | US7268135 Biaryl sulfonamides and methods for using same |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | CA2555051C Process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine |
| 09/11/2007 | CA2433839C Primary intermediates for oxidative coloration of hair |
| 09/11/2007 | CA2432064C Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 09/11/2007 | CA2070419C Synthesis and use of amino acid fluorides as peptide coupling reagents |
| 09/07/2007 | WO2007099423A1 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists |
| 09/07/2007 | WO2007098826A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 09/07/2007 | WO2006041888A3 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents |
| 09/07/2007 | CA2642813A1 Inhibitors of histone deacetylase |
| 09/07/2007 | CA2637530A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 09/06/2007 | US20070208166 Tao Kinase Modulators And Method Of Use |
| 09/06/2007 | US20070208032 Chemical compounds |
| 09/06/2007 | US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 09/05/2007 | EP1828160A1 Sulfonyl amino cyclic derivatives and use thereof as mmp inhibitors |
| 09/05/2007 | EP1828156A2 N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 09/05/2007 | EP1828155A2 Diuretic compounds comprising heterocyclic nitric oxide donor groups,compositions and methods of use |
| 09/05/2007 | EP1828142A1 Method for producing onium alkyl sulfates with a low halogenide content |
| 09/05/2007 | EP1828109A2 Guanidine derivatives as inhibitors of ddah |
| 09/05/2007 | EP1689698A4 Bis-cationic compounds and use thereof |
| 09/05/2007 | EP1487811B1 N-sulfonylurea apoptosis promoters |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | EP1057815B1 Cyclic amide compounds |
| 09/05/2007 | EP0993452B1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 09/05/2007 | CN101031564A Piperazine derivatives useful for the treatment of gastrointestinal disorders |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN100335468C Diaryl amidine compound, its production, medicinal composition and use |
| 09/05/2007 | CN100335461C Arylsulfonanilide ureas |
| 09/05/2007 | CN100335427C Oxygen scavenger and boiler water treatment chemical |
| 09/05/2007 | CN100335041C Palatable chewable tablet |
| 09/04/2007 | US7265228 N-(alpha-methylolbenzyl)1-(aminoethyl)- or 1-(aminocarbonyl)-2-aryl(especially phenyl or benzodioxanyl)-2-hydroxyethylamine intermediates for enantiomeric synthesis of amino ceramide-like compounds |
| 09/04/2007 | US7265220 Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 09/04/2007 | US7265130 anti-obestic activity; Neuropeptide Y antagonist |
| 09/04/2007 | US7265110 Psychological disorders; antidepressants; anxiolytic agents; analgesics; antiinflammatory agents; central nervous system disorders |
| 09/04/2007 | US7265109 Thiazole derivatives |
| 09/04/2007 | CA2258044C Muscarinic antagonists |
| 08/30/2007 | WO2007096251A1 Inhibitors of cpt in the central nervous system as antidiabetic and/or anti-obesity drugs |
| 08/30/2007 | US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |